Prof Jaap van Laar, Editor of the journal 'Rheumatology' and Dr Eric Matteson, Mayo Clinic, Rochester, USA, discuss the study about the level of dosing of corticosteroids in giant cell arthritis in their retrospective cohort study over a 15-year period.
http://rheumatology.oxfordjournals.or...
They talk about the rationale for this study, their key observations, why some patients relapse and why some patients need to be treated longer than others, or suffer more from side effects due to long steroid exposure. Dr Matteson talks about the findings from this study and surmises that actually it might be better to start with a higher dose in the first place.

© Oxford University Press